The Association of Elective Cessation of Tocolysis and Preterm Birth in Singleton Gestations

ABSTRACT

We evaluated outcomes following tocolysis discontinuation in singleton pregnancies between 33.0 and 36.9 weeks' gestation. We performed a retrospective analysis of singleton pregnancies prescribed continuous subcutaneous terbutaline tocolysis. Patients without indicated preterm delivery discontinuing treatment between 33.0 and 36.9 weeks were evaluated (n = 4253). Data were grouped by week at treatment discontinuation. Outcomes were compared for each week. Approximately 55% (2316/4253) delivered preterm (< 37 weeks). After treatment discontinuation, 58.1% (2472/4253) of patients delivered within 7 days and 41.2% (1752/4253) within 3 days. Median number of days from discontinuation to delivery was 5 (range, 0 to 65). Incidence of low birth weight (≤ 2500 g), neonatal intensive care unit admissions, days in nursery, and estimated charges decreased with each additional week of tocolysis (all p < 0.05, adjusted for multiple comparisons). Tocolysis discontinuation prior to term is associated with late-preterm birth, adverse neonatal outcomes, and increased estimated health care costs.

Late-preterm birth - neonatal outcome - prematurity cost - terbutaline - tocolysis

REFERENCES

• 1 Raju T NK. Late-preterm births: challenges and opportunities.  Pediatrics. 2008;  121 402-403
• 2 McIntire D D, Leveno K J. Neonatal mortality and morbidity rates in late-preterm births compared with births at term.  Obstet Gynecol. 2008;  111 35-41
• 3 Davidoff M J, Dias T, Damus K et al.. Changes in the gestational age distribution among U.S. singleton births: impact on late-preterm birth, 1992 to 2002.  Semin Perinatol. 2006;  30 8-15
• 4 Shapiro-Mendoza C K, Tomashek K M, Kotelchuck M et al.. Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk.  Pediatrics. 2008;  121 e223-e232
• 5 March of Dimes, Office of the Medical Director .Late-Preterm Birth: Every Week Matters. White Plains, NY; March of Dimes 2006 (Medical Perspectives on Prematurity)
• 6 Medoff-Cooper B, Bakewell-Sachs S, Buus-Frank M E, Santa-Donato A. The AWHONN near-term infant initiative: a conceptual framework for optimizing health for near-term infants.  J Obstet Gynecol Neonatal Nurs. 2005;  34 666-671
• 7 Fox N S, Gelber S E, Kalish R B, Chasen S T. Contemporary practice patterns and beliefs regarding tocolysis among U.S. maternal-fetal medicine specialists.  Obstet Gynecol. 2008;  112 42-47
• 8 Sanchez-Ramos L, Kaunitz A M, Gaudier F L, Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis.  Am J Obstet Gynecol. 1999;  181 484-490
• 9 Management of Preterm Labor .American College of Obstetricians and Gynecologists Practice Bulletin, number 43. May 2003 Washington, DC; The American College of Obstetricians and Gynecologists
• 10 Rebarber A, Ferrara L A, Hanley M L et al.. Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate.  Am J Obstet Gynecol. 2007;  196 224. e1-4
• 11 Berkman N D, Thorp J M, Lohr K N et al.. Tocolytic treatment for the management of preterm labor: a review of the literature.  Am J Obstet Gynecol. 2003;  188 1648-1659
• 12 Lam F, Gill P J, Smith M, Kitzmiller J L, Katz M. Use of subcutaneous terbutaline pump for long-term tocolysis.  Obstet Gynecol. 1988;  72 810-813
• 13 Lam F, Gill P. B-agonist tocolytic therapy.  Obstet Gynecol Clin North Am. 2005;  32 457-484
• 14 Fleming A, Bonebrake R, Istwan N, Rhea D, Coleman S, Stanziano G. Pregnancy and economic outcomes in patients treated for recurrent preterm labor.  J Perinatol. 2004;  24 223-227
• 15 Lam F, Istwan N B, Jacques D, Coleman S K, Stanziano G J. Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor.  Manag Care. 2003;  12 39-46
• 16 Morrison J C, Chauhan S P, Carroll C S et al.. Continuous subcutaneous terbutaline administration prolongs pregnancy after recurrent preterm labor.  Am J Obstet Gynecol. 2003;  188 1460-1467
• 17 Jones J S, Morrison J, Istwan N et al.. The interval to spontaneous delivery following discontinuation of maintenance tocolysis.  J Matern Fetal Neonatal Med. 2006;  19 331-335